학술논문
Cost-effectiveness of stockpiling 23-valent pneumococcal polysaccharide vaccine to prevent secondary pneumococcal infections among a high-risk population in the united states during an influenza pandemic
Document Type
Article
Source
In Clinical Therapeutics 2010 32(8):1501-1516
Subject
Language
ISSN
0149-2918